1 |
Wu Q, Schapira M, Arrowsmith CH, Barsyte-Lovejoy D. Protein arginine methylation: from enigmatic functions to therapeutic targeting. Nat Rev Drug Discov 2021;20:509-30. [PMID: 33742187 DOI: 10.1038/s41573-021-00159-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
|
2 |
Janisiak J, Kopytko P, Tarnowski M. Dysregulation of protein argininemethyltransferase in the pathogenesis of cancerpy. Postepy Hig Med Dosw 2021;75:272-82. [DOI: 10.5604/01.3001.0014.8521] [Reference Citation Analysis]
|
3 |
Bajbouj K, Ramakrishnan RK, Saber-Ayad M, Omar HA, Saheb Sharif-Askari N, Shafarin J, Elmoselhi AB, Ihmaid A, AlHaj Ali S, Alalool A, Abdullah R, Hamid Q. PRMT5 Selective Inhibitor Enhances Therapeutic Efficacy of Cisplatin in Lung Cancer Cells. Int J Mol Sci 2021;22:6131. [PMID: 34200178 DOI: 10.3390/ijms22116131] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
4 |
Janisiak J, Kopytko P, Tkacz M, Rogińska D, Perużyńska M, Machaliński B, Pawlik A, Tarnowski M. Protein Arginine Methyltransferase (PRMT) Inhibitors-AMI-1 and SAH Are Effective in Attenuating Rhabdomyosarcoma Growth and Proliferation in Cell Cultures. Int J Mol Sci 2021;22:8023. [PMID: 34360791 DOI: 10.3390/ijms22158023] [Reference Citation Analysis]
|
5 |
Esperança-Martins M, Fernandes I, Soares do Brito J, Macedo D, Vasques H, Serafim T, Costa L, Dias S. Sarcoma Metabolomics: Current Horizons and Future Perspectives. Cells 2021;10:1432. [PMID: 34201149 DOI: 10.3390/cells10061432] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|